All articles by MarketLine  

Johnson & Johnson splits into two as big pharma downsizes

The company’s decision to split is likely being made so it can focus on its fast-growing pharmaceutical and medical device units.

JD Health squares off to Alibaba in online healthcare with trading debut success

JD Health share price closed in green at 56% growth in the end of its first day of listing, which ended up with the company raising $3.5bn.

AstraZeneca successfully clears out the first trial for the Covid-19 vaccine, boosting its share price

AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history

Sanofi restructure investment to focus on blooming business ventures

Covid-19 epidemic will reshape patient behaviour, accelerating digitalisation of healthcare system

Pharmaceuticals contrasts travel and tourism following China’s coronavirus outbreak

Psilocybin moves closer to becoming a licensed treatment for depression

Inclisiran drives Novartis to buy The Medicines Company

Climate change means fresh opportunities for pharmaceutical companies

225 of the world’s largest corporations highlighted roughly $2.1 trillion of possible opportunities to capitalise on climate change, including big pharma.